This is a French Registry mandated by the French National Health Authority assessing long-term (5-years) safety of the GORE® Excluder® Endoprosthesis in the treatment of infra-renal Abdominal Aortic Aneurysms (AAA).
The use of abdominal aortic endoprostheses makes the treatment of infra-renal abdominal aortic aneurysms possible, with implantation via the femoral artery, thus avoiding a very invasive surgical procedure. The French National Authority for Health requires a 5-year follow-up as part of the renewal for reimbursement for these endoprostheses.
Study Type
OBSERVATIONAL
Enrollment
181
Endovascular therapy to treat abdominal aortic aneurysms
Centre Hospitalier de Dijon
Dijon, France
Percentage of Participants Survived at 5 Years
Kaplan-Meier estimate of participant survival at 5 years
Time frame: 5 years
Percentage of Participants Free From Endoleak at 5 Years
Kaplan-Meier estimate of participant freedom from endoleak (Type I, II and III) at 5 years
Time frame: 5 years
Percentage of Participants Free From Migration at 5 Years
Kaplan-Meier estimate of participant freedom from migration at 5 years
Time frame: 5 years
Percentage of Participants Free From Aneurysm Diameter Growth at 5 Years
Kaplan-Meier estimate of participant freedom from aneurysm diameter growth at 5 years
Time frame: 5 years
Percentage of Participants Free From Aneurysm Related Mortality at 5 Years
Kaplan-Meier estimate of participant freedom from aneurysm related mortality at 5 years
Time frame: 5 years
Percentage of Participants Free From Endovascular or Surgical Re-intervention at 5 Years
Kaplan-Meier estimate of participant freedom from endovascular or surgical re-intervention at 5 years
Time frame: 5 years
Percentage of Participants Free From Surgical Conversion at Procedure
Participant freedom from surgical conversion at procedure
Time frame: Index Procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.